Aspen Pharmacare 

$8.90
37
+$0.10+1.09% Tuesday 20:00

Statistics

Day High
8.8
Day Low
8.8
52W High
8.9
52W Low
6.23
Volume
100
Avg. Volume
4
Mkt Cap
3.97B
P/E Ratio
-
Dividend Yield
1.38%
Dividend
0.12

Upcoming

Dividends

1.38%Dividend Yield
Oct 25
$0.12
Sep 24
$0.21
Sep 23
$0.18
Sep 22
$0.18
Sep 21
$0.18
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-12%
1Y Growth
-40.56%

Earnings

2SepExpected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0
0.18
0.37
0.55
Expected EPS
N/A
Actual EPS
N/A

Financials

-2.72%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.37BRevenue
-64.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APNHF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Aspen in various therapeutic areas, including anti-infectives and cardiovascular drugs.
Novartis
NVS
Mkt Cap292.35B
Novartis is a multinational pharmaceutical company that competes across several of the same therapeutic areas as Aspen, including generic medicines through its Sandoz division.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that compete with Aspen's portfolio, including in the areas of women's health and general medicines.
Merck
MRK
Mkt Cap366B
Merck is a global healthcare company that competes with Aspen, particularly in the areas of infectious diseases and cardiovascular health.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes with Aspen in the development and marketing of pharmaceuticals and vaccines, including in respiratory diseases and HIV.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes with Aspen in the pharmaceutical sector, particularly in the areas of immunology and oncology, areas Aspen is expanding into.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes with Aspen, offering a broad portfolio of drugs that overlap with Aspen's, including in the areas of cardiovascular diseases and central nervous system disorders.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a leading generic pharmaceutical company that competes with Aspen's manufacturing and distribution of generic medicines.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes with Aspen in several therapeutic areas, including respiratory, cardiovascular, and metabolic diseases, areas where Aspen also operates.

About

Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities are structured into two main divisions: Commercial Pharmaceuticals and Manufacturing. Under its Anaesthetics portfolio, Aspen offers diverse products such as general anesthetics, muscle relaxants, and topical agents. Its Thrombosis brand is dedicated to a variety of injectable anticoagulants, with an emphasis on low molecular weight heparins, Xa inhibitors, and heparin derivatives. Additionally, Aspen provides a range of branded consumer, prescription, and over-the-counter medications through regional brands. These include Circadin (for sleep management), Foxair (for respiratory conditions), Maltofer (an iron supplement), Mybulen (a painkiller), and Zyloric (which controls uric acid production). Beyond its proprietary offerings, the company also manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage form products to external clients. Founded in 1850, Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Show more...
CEO
Stephen Bradley Saad
Employees
9557
Country
South Africa
ISIN
ZAE000066692
WKN
000A0ET80

Listings

0 Comments

Share your thoughts

FAQ

What is Aspen Pharmacare stock price today?
The current price of APNHF is $8.90 USD — it has increased by +1.09% in the past 24 hours. Watch Aspen Pharmacare stock price performance more closely on the chart.
What is Aspen Pharmacare stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Aspen Pharmacare stocks are traded under the ticker APNHF.
What is Aspen Pharmacare market cap?
Today Aspen Pharmacare has the market capitalization of 3.97B
When is the next Aspen Pharmacare earnings date?
Aspen Pharmacare is going to release the next earnings report on March 11, 2027.
What is Aspen Pharmacare revenue for the last year?
Aspen Pharmacare revenue for the last year amounts to 2.37B USD.
What is Aspen Pharmacare net income for the last year?
APNHF net income for the last year is -64.41M USD.
Does Aspen Pharmacare pay dividends?
Yes, APNHF dividends are paid annual. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 1.38%.
How many employees does Aspen Pharmacare have?
As of September 04, 2026, the company has 9,557 employees.
In which sector is Aspen Pharmacare located?
Aspen Pharmacare operates in the Health & Wellness sector.
When did Aspen Pharmacare complete a stock split?
The last stock split for Aspen Pharmacare was on July 18, 2012 with a ratio of 5:1.
Where is Aspen Pharmacare headquartered?
Aspen Pharmacare is headquartered in Durban, South Africa.